The Wall Street Journal: First-ever digital drug gets FDA approval

U.S. authorities approved the world’s first digital drug, an antipsychotic pill that signals smartphones once it reaches the gut so doctors can track whether patients are taking their medication.

Tuesday’s green light from the Food and Drug Administration means Japan’s Otsuka Pharmaceutical Co. can implant a tiny chip containing minerals like silicon, magnesium and copper inside tablets of Abilify, which is used to treat schizophrenia, bipolar disorder and other mental illnesses.

Once swallowed, the chip mixes with stomach acids and sends a heartbeat-like signal to an adhesive patch worn on a patient’s torso. The patch records the dosage and time of ingestion and relays this to a smartphone app for patients to monitor and share with doctors and caretakers. The chip ultimately passes through the digestive tract normally.

Otsuka, whose parent company is Otsuka Holdings Co. Inc. 4578, +0.50%  , spent years testing the drug with Silicon Valley company Proteus Digital Health Inc., which provided the chip technology.

An expanded version of this report appears on WSJ.com.

Also popular on WSJ.com:

Surveillance cameras made by China are hanging all over the U.S.

Bitcoin plunges more than 25% over four days.

Filed in: Top News Tags: 

You might like:

America owes millennials an apology — everyone blows their budgets eating out America owes millennials an apology — everyone blows their budgets eating out
The Wall Street Journal: Anbang Insurance Group taken over by Chinese regulators The Wall Street Journal: Anbang Insurance Group taken over by Chinese regulators
Where you sit at the office could influence your next promotion Where you sit at the office could influence your next promotion
NRA backlash: Major bank and car-rental giant are ending partnerships NRA backlash: Major bank and car-rental giant are ending partnerships
Asia Markets: Asian stocks jump to early gains after Dow’s rebound Asia Markets: Asian stocks jump to early gains after Dow’s rebound
What’s better for you: a low-fat or low-carb diet? Scientists have an answer What’s better for you: a low-fat or low-carb diet? Scientists have an answer
The New York Post: Did a Kylie Jenner tweet really prompt Snap shares to tumble? The New York Post: Did a Kylie Jenner tweet really prompt Snap shares to tumble?
MarketWatch First Take: HP Enterprise earnings jolt stock, but there isn’t much to be excited about MarketWatch First Take: HP Enterprise earnings jolt stock, but there isn’t much to be excited about

Leave a Reply

Submit Comment
© 8190 Stock Investors News. All rights reserved. XHTML / CSS Valid.